STE.NYSESteris PLC

Form 4: STERIS Executive Reports Tax-Related Share Withholding

Sentiment:

Statement of Changes in Beneficial Ownership


John Adam Zangerle, Senior VP and General Counsel at STERIS plc, reported the withholding of 365 shares to cover tax obligations upon the vesting of restricted stock.

Summary

  • John Adam Zangerle, Senior VP, General Counsel, and Secretary of STERIS plc, executed a transaction on June 3, 2026.
  • The transaction involved the withholding of 365 ordinary shares to satisfy tax withholding requirements related to the vesting of 1,252 restricted shares.
  • The shares were valued at $210.19 per share based on the NYSE closing price.
  • Following this transaction, the reporting person maintains a direct beneficial ownership of 37,079 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax withholding transaction by an executive.

Positives

  • The transaction is a routine administrative action related to tax obligations upon the vesting of equity compensation, rather than a discretionary sale of shares.

Negatives

  • None identified; this is a standard regulatory disclosure for executive compensation tax compliance.

Risks

  • None identified; the filing pertains to routine tax withholding.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a disclosure of individual insider equity activity.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory requirement for corporate insiders and does not reflect a change in company strategy or market outlook.

Comparison to Industry Standards

  • The transaction follows standard corporate governance practices for equity-based compensation tax withholding, consistent with practices at other large-cap medical device companies.

Stakeholder Impact

  • Minimal impact on shareholders as the transaction is a non-discretionary tax compliance event.

Next Steps

  • Future vesting of restricted shares scheduled through June 4, 2029.

Key Dates

DateDescription
06/03/2026Date of the transaction and vesting of restricted shares.
06/04/2026Scheduled lapse of restrictions for 1,376 shares.
06/05/2026Date of filing signature.

Keywords

STERIS, STE, Form 4, Insider Trading, Equity Compensation, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.